19-8056190-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_005624.4(CCL25):āc.112A>Gā(p.Ile38Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000919 in 1,556,716 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I38T) has been classified as Uncertain significance.
Frequency
Consequence
NM_005624.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCL25 | NM_005624.4 | c.112A>G | p.Ile38Val | missense_variant | 3/6 | ENST00000315626.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCL25 | ENST00000315626.6 | c.112A>G | p.Ile38Val | missense_variant | 3/6 | 2 | NM_005624.4 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000337 AC: 5AN: 148564Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000194 AC: 4AN: 206466Hom.: 0 AF XY: 0.0000271 AC XY: 3AN XY: 110566
GnomAD4 exome AF: 0.0000980 AC: 138AN: 1408152Hom.: 1 Cov.: 32 AF XY: 0.0000849 AC XY: 59AN XY: 694968
GnomAD4 genome AF: 0.0000337 AC: 5AN: 148564Hom.: 0 Cov.: 31 AF XY: 0.0000416 AC XY: 3AN XY: 72056
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 10, 2023 | The c.112A>G (p.I38V) alteration is located in exon 3 (coding exon 2) of the CCL25 gene. This alteration results from a A to G substitution at nucleotide position 112, causing the isoleucine (I) at amino acid position 38 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at